Rituximab Ineffective as Lupus Nephritis Add-On Therapy - Renal and Urology News PDF Print
Renal and Urology News
As part of the Lupus Nephritis Assessment with Rituximab (LUNAR) trial, American and Mexican investigators led by Brad H. Rovin, MD, Director of Nephrology at the Ohio State College of Medicine in Columbus, Ohio, studied 144 patients (aged 16-75 years)

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.